TransTech Digest: Why Mitochondria Matter By Patrick Cox I may sound like a broken record saying this again, but it’s critical that we realize that scientific understanding of the biological world is increasing at an exponential rate. For younger readers, I should explain that the term “broken record” is a reference to a common failure […]
TransTech Digest: Why Mitochondria Matter Read More »
Connecting the Dots: The Ticking Time Bomb of the Strong US Dollar By Tony Sagami Get used to the headlines like the one below. You’re going to hear hundreds of US multinational companies blame their profit shortfalls on the strong dollar. Revenue Miss #1: Lockheed Martin rose sharply after reporting better-than-expected quarterly profits. However, their $11.11
The Ticking Time Bomb of the Strong US Dollar Read More »
Biotech Stocks Hit to New Concerns: Gilead Sciences, Inc.(NASDAQ:GILD), CEL …StreetWise ReportCEL-SCI Corporation (NYSE: CVM) declared the 7,894,737 share of common stock in an underwritten public offering closed and 1,973,684 warrants to buying shares of common stock. For each 4 shares of common stock traded, firm released to investors in … and more …read more
Relmada Therapeutics Adds $15 Million in Capital to Expedite Development of …StockhouseNEW YORK, NY–(Marketwired – October 29, 2014) – Relmada Therapeutics, Inc. (OTCQB: RLMD), a biopharmaceutical firm with four novel pain treatment drugs currently under development in its pipeline, received a healthy injection of more than $15 million … and more …read more
AtheroNova Prices Public Offering of Common Stock and WarrantsVirtual Press Office (press release)The securities are offered at a price to the public of $0.75 per share of common stock and $0.01 per warrant. The warrants will have an exercise price of $4.00 per share, subject to adjustment, and are exercisable immediately and will expire 5
AtheroNova Prices Public Offering of Common Stock and WarrantsDigitalJournal.comThe securities are offered at a price to the public of $0.75 per share of common stock and $0.01 per warrant. The warrants will have an exercise price of $4.00 per share, subject to adjustment, and are exercisable immediately and will expire 5 (five … and more
AtheroNova Prices Public Offering of Common Stock and Warrants – DigitalJournal.com Read More »
AtheroNova Prices Public Offering of Common Stock and WarrantsPR Newswire (press release)The securities are offered at a price to the public of $0.75 per share of common stock and $0.01 per warrant. The warrants will have an exercise price of $4.00 per share, subject to adjustment, and are exercisable immediately and will expire 5 (five
AtheroNova Prices Public Offering of Common Stock and WarrantsMarketWatchThe securities are offered at a price to the public of $0.75 per share of common stock and $0.01 per warrant. The warrants will have an exercise price of $4.00 per share, subject to adjustment, and are exercisable immediately and will expire 5 (five … and more
AtheroNova Prices Public Offering of Common Stock and Warrants – MarketWatch Read More »
Applied DNA Sciences Announces Reverse Stock SplitGlobeNewswire (press release)The reverse stock split will reduce the number of shares of APDN’s outstanding common stock from 836,157,272 to approximately 13,935,954. Proportional adjustments will be made to APDN’s outstanding stock options, and outstanding warrants. The number … and more …read more
Applied DNA Sciences Announces Reverse Stock Split – GlobeNewswire (press release) Read More »
Applied DNA Sciences Announces Reverse Stock SplitGlobeNewswire (press release)The reverse stock split will reduce the number of shares of APDN’s outstanding common stock from 836,157,272 to approximately 13,935,954. Proportional adjustments will be made to APDN’s outstanding stock options, and outstanding warrants. The number … and more …read more
Applied DNA Sciences Announces Reverse Stock Split – GlobeNewswire (press release) Read More »